Targeting tumor lineage plasticity in hepatocellular carcinoma using an anti-CLDN6 antibody-drug conjugate.
Kong FE, Li GM, Tang YQ, Xi SY, Loong JHC, Li MM, Li HL, Cheng W, Zhu WJ, Mo JQ, Gong YF, Tang H, Zhao Y, Zhang Y, Ma S, Guan XY, Ma NF, Xie MB, Liu M.
Kong FE, et al.
Sci Transl Med. 2021 Feb 3;13(579):eabb6282. doi: 10.1126/scitranslmed.abb6282.
Sci Transl Med. 2021.
PMID: 33536280